Nuclear medicine : radioactivity for diagnosis and therapy /

Nuclear medicine is a growing specialized medical field in which radiopharmaceuticals, i.e. drugs associated to radioactivity, are used for diagnostic or therapeutic purposes. Since 1942, nuclear medicine has progressed in such a way that it became a major diagnostic tool in hospitals. The past ten...

Full description

Saved in:
Bibliographic Details
Main Author: Zimmermann, Richard (Author)
Other Authors: Pouchot, Pascal (Illustrator)
Format: Electronic eBook
Language:English
French
Published: Les Ulis, France : EDP Sciences, 2017.
Edition:2nd edition
Series:Hors Collection.
Subjects:
Online Access: Full text (Wentworth users only)
Local Note:ProQuest Ebook Central

MARC

LEADER 00000cam a2200000 i 4500
001 in00000268628
006 m o d
007 cr |n|||||||||
008 190217s2017 fr ob 000 0 eng d
005 20240806210139.0
019 |a 1003311753  |a 1004190178  |a 1015372291  |a 1107344832  |a 1115078253  |a 1228599154  |a 1267426052 
020 |a 9782759821495  |q (electronic bk.) 
020 |a 2759821498  |q (electronic bk.) 
020 |a 2759821404 
020 |a 9782759821402 
020 |z 9782759821402 
035 |a (OCoLC)1088984290  |z (OCoLC)1003311753  |z (OCoLC)1004190178  |z (OCoLC)1015372291  |z (OCoLC)1107344832  |z (OCoLC)1115078253  |z (OCoLC)1228599154  |z (OCoLC)1267426052 
035 |a (OCoLC)on1088984290 
040 |a VT2  |b eng  |e rda  |e pn  |c VT2  |d N$T  |d OCLCF  |d G3B  |d STF  |d D6H  |d IGB  |d USU  |d OCLCO  |d EBLCP  |d YDX  |d EZ9  |d CUY  |d LOA  |d ZCU  |d MERUC  |d ICG  |d COCUF  |d DKC  |d OCLCO  |d UX1  |d OCLCA  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL  |d TMA  |d OCLCQ  |d SXB 
041 1 |a eng  |h fre 
050 4 |a R895 
060 4 |a WN 440 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
080 |a 616-073  |b Z56 
082 0 4 |a 616.07575 
100 1 |a Zimmermann, Richard,  |e author. 
245 1 0 |a Nuclear medicine :  |b radioactivity for diagnosis and therapy /  |c Richard Zimmerman ; illustrations by Pascal Couchot. 
250 |a 2nd edition 
264 1 |a Les Ulis, France :  |b EDP Sciences,  |c 2017. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Hors Collection 
500 |a Title from content provider. 
504 |a Includes bibliographical references. 
505 0 |a Nuclear medicine, what for? -- A little history -- Some basic notions about radiation -- SPECT imaging : gamma ray imaging -- PET imaging : positron emission tomography -- Therapeutic applications -- The development of rRadiopharmaceuticals -- The production of radiopharmaceuticals -- The future of nuclear medicine. 
520 |a Nuclear medicine is a growing specialized medical field in which radiopharmaceuticals, i.e. drugs associated to radioactivity, are used for diagnostic or therapeutic purposes. Since 1942, nuclear medicine has progressed in such a way that it became a major diagnostic tool in hospitals. The past ten years have seen the introduction of major technical breakthroughs which will considerably modify the landscape of cancer treatment. Once injected to the patient, the radiopharmaceutical drug aims at the tumour cell - including metastases - selectively, settles there, and emits radiation. Depending on the radiation type, the drug will either help identify the cells or destroy them. Applications are not limited to oncology; indeed, nuclear medicine has found interesting applications in cardiology and neurology as well. The new millennium saw the introduction of the Hybrid imaging technology PET/CT which combines the Positron Emission Tomography (PET) modality with conventional high quality x-ray imaging. It took another two years until PET could be combined with Magnetic Resonance Imaging (MRI) in the hybrid equipment PET/MR. New tracers (drugs for diagnosis) also came on the market with different diseases as targets, such as prostate cancer, neuroendocrine tumours, or Alzheimer's disease. But the recent introduction of radiotherapeutics in the treatment of cancer has brought major changes on the market, for they can be much more powerful and specific than chemotherapeutics or external radiation therapy. Combining radiodiagnostics to select positive responders to a treatment with efficient radiotherapeutics opens a highway for the development of theranostics, another word for personalized medicine. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties met by both physicians and patients when trying to access new technologies. This second edition shows how much progress has been made over the past ten years since the original book was published, and how much can be expected for patients within the next few years. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Nuclear medicine. 
650 2 |a Nuclear Medicine 
700 1 |a Pouchot, Pascal,  |e illustrator. 
758 |i has work:  |a Nuclear medicine (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFwpMWwdK6fWtdwRJcJfVP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Zimmermann, Richard.  |t Nuclear Medicine : Radioactivity for Diagnosis and Therapy.  |d Les Ulis : EDP Sciences, ©2017 
830 0 |a Hors Collection. 
852 |b Ebooks  |h ProQuest 
856 4 0 |u https://ebookcentral.proquest.com/lib/wit/detail.action?docID=5024612  |z Full text (Wentworth users only)  |t 0 
947 |a FLO  |x pq-ebc-base 
999 f f |s f6b1ecbe-d8eb-4164-8ab5-329624b34bef  |i b427dd20-ac9c-4267-a680-26ea83b8b072  |t 0 
952 f f |a Wentworth Institute of Technology  |b Main Campus  |c Wentworth Library  |d Ebooks  |t 0  |e ProQuest  |h Other scheme 
856 4 0 |t 0  |u https://ebookcentral.proquest.com/lib/wit/detail.action?docID=5024612  |y Full text (Wentworth users only)